Results 231 to 240 of about 734,282 (319)

A bibliometric analysis of atezolizumab in hepatocellular carcinoma. [PDF]

Discov Oncol
Xu Y, Zhang H, Yu H.
europepmc   +1 more source

Targeting IL27RA Enhances Immunotherapy in Triple‐Negative Breast Cancer by Modulating Tumor Cells and the Tumor Microenvironment

Advanced Science, EarlyView.
IL27RA upregulation drives immune evasion in TNBC by suppressing MHC‐I expression and reprogramming T/NK‐cell states, establishing an immune‐excluded tumor phenotype. Targeting this epithelial‐intrinsic IL27RA–PI3K/AKT axis offers a promising strategy to overcome immunotherapy resistance.
Jiachi Xu, Qian Long, Meirong Zhou, Qitong Chen, Jing Peng, Qingchun Liang, Danhua Zhang, Hui Zhou, Wenjun Yi   +8 more
wiley   +1 more source

Alcohol induces sorafenib resistance in hepatocellular carcinoma: A translational study. [PDF]

J Mol Med (Berl)
Courtois A, Marié C, Fouquet G, Diouf M, Esparteiro D, Ducournau G, Marticho L, Naassila M, Nguyen-Khac E, Marcq I.   +9 more
europepmc   +1 more source

Core Fucosylation Represses SMURF1‐Dependent Degradation of CD47 to Promote Tumor Immune Evasion

Advanced Science, EarlyView.
FUT8‐mediated core fucosylation of CD47 at N111 blocks SMURF1 binding and reduces CD47 ubiquitination and degradation. Blocking N111 glycosylation reduces CD47 expression and promotes macrophage phagocytosis of tumor cells. Furthermore, ablating CD47 core fucosylation boosts CD103+ dendritic cells (DCs) infiltration, increases natural killer (NK) cell ...
Yuting Cao, Siyuan Chai, Mingyang Li, Xiaoming Chen, Jiating Hu, Bingyi Lin, Liming Wu, Wen Yi, Qiang Zhu   +8 more
wiley   +1 more source

Sleep disorders in hepatocellular carcinoma. [PDF]

World J Gastrointest Oncol
Qian J, Ruan MH, Wang ZJ, Dong W, Jia JY, Feng XC, Liu H.   +6 more
europepmc   +1 more source

The Effect of Low HBV-DNA Viral Load on Recurrence in Hepatocellular Carcinoma Patients Who Underwent Primary Locoregional Treatment and the Development of a Nomogram Prediction Model [PDF]

Yiqi Xiong, Ziling Wang, Jiajun Liu, Kang Li, Yonghong Zhang   +4 more
openalex   +1 more source

OCTN2 Activates a Non‐Canonical Carnitine Metabolic Pathway to Promote MASH‐HCC Progression and Immunotherapy Resistance

Advanced Science, EarlyView.
In non‐MASH‐HCC, L‐carnitine promotes tumor progression primarily through its classical role in enhancing fatty acid oxidation (FAO). However, in MASH‐HCC, where FAO is markedly suppressed, L‐carnitine shifts from this canonical function to serve instead as an intracellular acetyl group buffer.
Chuqi Xia, Xiao Zhang, Jinze Li, Ning Xu, Sheng Hu, Qiyu Lu, Yuxuan Li, Taifu Xiao, Xu Li, Xue Wang, Kequan Xu, Daoming Liang   +11 more
wiley   +1 more source

PANoptosis in hepatocellular carcinoma: Underlying mechanisms. [PDF]

World J Hepatol
Li MJ, Wen CL, Cheng HT, Lyu HN, Han YY.
europepmc   +1 more source

Prognostic significance of exportin-5 in hepatocellular carcinoma

Hao Li, Fei Li, Boshen Wang, Baoli Zhu
openalex   +1 more source

Actopaxin : a novel regulator of cell migration and invasion in human hepatocellular carcinoma

, 2012
Lui Ng
openalex   +1 more source